BMPs go for apelin to regulate angiogenesis. Focus on "Inhibition of apelin expression by BMP signaling in endothelial cells"

American Journal of Physiology - Cell Physiology

Volumn 303, Issue 11, 2012, Pages

  Ciais, Delphine ^a,b,c   Bailly, Sabine ^a,b,c  

^a INSERM   (France)

^b DIF   (France)

^c UNIV GRENOBLE ALPES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; APELIN; BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; EDITORIAL; ENDOTHELIUM CELL; GENE TARGETING; HUMAN; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; RISK FACTOR;

BONE MORPHOGENETIC PROTEINS; ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; SIGNAL TRANSDUCTION;

EID: 84870508251     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00283.2012     Document Type: Editorial

References (12)

1. Alastalo TP, Li M, Perez Vde J, Pham D, Sawada H, Wang JK, Koskenvuo M, Wang L, Freeman BA, Chang HY, Rabinovitch M. Disruption of PPARgamma/beta-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival. J Clin Invest 121: 3735-3746, 2011.
2. Andersen CU, Hilberg O, Mellemkjaer S, Nielsen-Kudsk JE, Simonsen U. Apelin and pulmonary hypertension. Pulm Circ 1: 334-346, 2011.
3. David L, Feige JJ, Bailly S. Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev 20: 203-212, 2009.
4. David L, Mallet C, Keramidas M, Lamande N, Gasc JM, Dupuis-Girod S, Plauchu H, Feige JJ, Bailly S. Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ Res 102: 914-922, 2008.
5. Devic E, Paquereau L, Vernier P, Knibiehler B, Audigier Y. Expression of a new G protein-coupled receptor X-msr is associated with an endothelial lineage in Xenopus laevis. Mech Dev 59: 129-140, 1996.
6. Kidoya H, Takakura N. Biology of the apelin-APJ axis in vascular formation. J Biochem 152: 125-131, 2012.
7. Larrivee B, Prahst C, Gordon E, Del Toro R, Mathivet T, Duarte A, Simons M, Eichmann A. ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway. Dev Cell 22: 489-500, 2012.
8. Lowery JW, de Caestecke MP. BMP signaling in vascular development, and disease. Cytokine Growth Factor Rev 21: 287-298, 2010.
9. McKenzie JA, Fruttiger M, Abraham S, Lange CA, Stone J, Gandhi P, Wang X, Bainbridge J, Moss SE, Greenwood J. Apelin is required for non-neovascular remodeling in the retina. Am J Pathol 180: 399-409, 2012.
10. Poirier O, Ciumas M, Eyries M, Montagne K, Nadaud S, Soubrier F. Inhibition of apelin expression by BMP signaling in endothelial cells. Am J Physiol Cell Physiol (August 15, 2012). doi:10.1152/ajpcell.00168.2012.
11. Ricard N, Ciais D, Levet S, Subileau M, Mallet C, Zimmers TA, Lee SJ, Bidart M, Feige JJ, Bailly S. BMP9 and BMP10 are critical for postnatal retinal vascular remodeling. Blood 119: 6162-6171, 2012.
12. Scimia MC, Hurtado C, Ray S, Metzler S, Wei K, Wang J, Woods CE, Purcell NH, Catalucci D, Akasaka T, Bueno OF, Vlasuk GP, Kaliman P, Bodmer R, Smith LH, Ashley E, Mercola M, Brown JH, Ruiz-Lozano P. APJ acts as a dual receptor in cardiac hypertrophy. Nature 488: 394-398, 2011